Vitalhub (TSE:VHI – Get Free Report) was upgraded by equities research analysts at TD Securities to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.
Separately, Cormark lifted their price objective on Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a report on Wednesday, October 2nd.
View Our Latest Research Report on VHI
Vitalhub Trading Down 1.3 %
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles
- Five stocks we like better than Vitalhub
- What is the Dogs of the Dow Strategy? Overview and Examples
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Investing In Preferred Stock vs. Common Stock
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Investors Need to Know About Upcoming IPOs
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.